Part 1: "Rapid" Acting Insulin Analogues & Inhaled Insulin in Pediatric Diabetes and Results of the INHALE-1 Trial: Ultra Rapid-Acting Insulins and Modes of Administration/Mechanisms of Action with Michael J. Haller, MD

Part 2: Overview of INHALE-1: Ultra Rapid-Acting Insulins and Modes of Administration/Mechanisms of Action with Michael J. Haller, MD

Part 3: Clinical Discussion & Q&A with Korey Hood, PhD and Michael J. Haller, MD

Part 1: Speeding Ahead, But Still Catching Up: Ultra Rapid-Acting Insulins and Modes of Administration/Mechanisms of Action with Julia Blanchette, PhD, RN, BC-ADM, CDCES

Part 2: Inhaled Insulin in Pediatric Diabetes Results of the INHALE-1 Trial with Michael J. Haller, MD

Part 3: Clinical Discussion & Q&A with Julia Blanchette, PhD, RN, BC-ADM, CDCES and Michael J. Haller, MD

Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs with Irl B. Hirsch, MD, MACP and Carol J. Levy, MD, CDCES.

Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs with Irl B. Hirsch, MD and David T. Ahn, MD.

Zobair M. Younossi, MD, Christina Hanson, FNP, Diana Isaacs, PharmD, and Marcelo Kugelmas, MD, present Arresting MASLD/MASH-Related Fibrosis Progression & Sequelae in PwD T2 at AACE '25

Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs with Irl B. Hirsch, MD and Desmond A Schatz, MD.